Pub. Date : 2021 Oct 16
PMID : 34681275
3 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Using virtual drug screening and molecular docking analyses, we identified FDA-approved compounds (conivaptan, bexarotene, and desloratadine) that were interacting with HMOX1 and PRKCA at even stronger binding affinities than 1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethenone and ellagic acid as known inhibitors of HMOX1 and PRKCA, respectively. | Bexarotene | heme oxygenase 1 | Homo sapiens |
2 | Using virtual drug screening and molecular docking analyses, we identified FDA-approved compounds (conivaptan, bexarotene, and desloratadine) that were interacting with HMOX1 and PRKCA at even stronger binding affinities than 1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethenone and ellagic acid as known inhibitors of HMOX1 and PRKCA, respectively. | Bexarotene | heme oxygenase 1 | Homo sapiens |
3 | Bexarotene treatment had a comparable doxorubicin-sensitizing effect in HMOX1-transfected cells and desloratadine in PRKCA-transfected cells. | Bexarotene | heme oxygenase 1 | Homo sapiens |